National Vision Holdings, Inc. Announces Repurchase of $100 Million of Convertible Notes
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision”) today announced that it has entered into agreements... Read more.
Bowman Acquires Reno-Based Engineering Firm CFA, Inc.
RESTON, Va.–(BUSINESS WIRE)–Bowman Consulting Group Ltd. (the “Company” or “Bowman”) (NASDAQ: BWMN), a national engineering services firm delivering... Read more.
CI Financial Announces Commencement of Substantial Issuer Bid
TORONTO–(BUSINESS WIRE)–$CIX #CIFinancial–CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) announced today it has commenced... Read more.
FORE Biotherapeutics Announces Oral Presentation of Phase 1/2a Plixorafenib Data at the Society for Neuro-Oncology 2023 Annual Meeting
PHILADELPHIA–(BUSINESS WIRE)–FORE Biotherapeutics today announced an oral presentation highlighting updated Phase 1/2a clinical data for plixorafenib... Read more.
Soho House & Co Inc. Announces Third Quarter 2023 Results
LONDON–(BUSINESS WIRE)–$SHCO–Soho House & Co Inc. (NYSE: SHCO) (“SHCO,” “Company,” “we” or “our”), a global membership platform... Read more.
JCR Pharmaceuticals Announces First Patient Dosed in a Global Phase I/II Clinical Trial of JR-441 for the Treatment of MPS IIIA
HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) announced today that the first... Read more.
Global Foot Care Products Strategic Analysis Report 2023: Market to Reach $4.4 Billion by 2030 from $2.9 Billion in 2022 – Manufacturers Focus on Enabling Self-Care, Educating Customers – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Foot Care Products – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s... Read more.
FDA Grants Orphan Drug Designation to MAIA Biotechnology for THIO as a Treatment for Glioblastoma
Third orphan drug designation (ODD) granted to THIO by the FDA; drug also holds ODDs for hepatocellular carcinoma and small cell lung cancer Benefits include 7 years... Read more.
Precision BioSciences to Present at Upcoming Sidoti Conference
DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform... Read more.
Electra Provides Notice of Third Quarter 2023 Results Conference Call and Webcast
TORONTO–(BUSINESS WIRE)–$ELBM—Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra”) will release its third quarter... Read more.